Yes, emerging evidence suggests intervertebral disc degeneration can lead to spinal cord injury through a cascade involving ferroptosis, iron deposition, and increased vulnerability.
Read the full answer →
Yes, Canadian policies for spinal cord injury supplies often use means-testing (income-based eligibility) rather than medical need, leading to wide inequities across provinces.
Read the full answer →
No, exosomes are not yet a safe or effective treatment for spinal cord injury in humans; evidence is limited to animal studies and early preclinical research.
Read the full answer →
Studies in animal models found that Danshen extract significantly improves motor function, reduces inflammation, oxidative stress, apoptosis, and spinal cord edema after spinal cord injury.
Read the full answer →
Yes, repetitive transcranial magnetic stimulation (rTMS) can reduce neuropathic pain in spinal cord injury patients, based on multiple studies including meta-analyses and randomized trials.
Read the full answer →